-
1.发明申请NON-REPLICATING PROBIOTIC MICRO-ORGANISMS PROTECT AGAINST UPPER RESPIRATORY TRACT INFECTIONS 审中-公开不重复上述呼吸道感染的微生物保护措施公开(公告)号：US20160250265A1
公开(公告)日：2016-09-01
申请号：US15151762
申请日：2016-05-11
Applicant: NESTEC S.A.
Inventor： Valerie Petit , Clara Lucia Garcia-Rodenas , Monique Julita , Annick Mercenier , Guenolee Prioult , Sophie Nutten
IPC: A61K35/747 , A61K35/744 , C12N1/36 , A61K35/745
CPC classification number: A61K35/747 , A61K35/74 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/745 , A61K38/00 , A61K39/00 , C12N1/20 , C12N1/36 , Y02A50/473
Abstract: The present invention relates to non-replicating probiotic micro-organisms and their health benefits. For example, the present invention relates to compositions comprising non-replicating probiotic micro-organisms for use in the treatment of prevention of upper respiratory tract infections and/or their symptoms. Embodiments of the present invention can help parents to protect their children from such upper respiratory tract infections.
Abstract translation: 本发明涉及非复制益生菌微生物及其健康益处。 例如，本发明涉及包含用于预防上呼吸道感染和/或其症状的非复制益生菌微生物的组合物。 本发明的实施例可以帮助父母保护他们的孩子免受这种上呼吸道感染。
-
2.发明申请EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS 审中-公开超微生物的非生物微生物及其健康益处公开(公告)号：US20160158297A1
公开(公告)日：2016-06-09
申请号：US15040492
申请日：2016-02-10
Applicant: NESTEC S.A.
Inventor： Annick Mercenier , Antoine Wermeille , Audrey Demont , Guenolee Prioult
IPC: A61K35/747 , A61K35/745
CPC classification number: A61K35/747 , A23K10/16 , A23K10/18 , A23K40/20 , A23K40/25 , A23L33/135 , A23P30/25 , A23V2002/00 , A23Y2220/03 , A23Y2220/15 , A23Y2220/17 , A23Y2220/43 , A23Y2220/49 , A23Y2220/63 , A23Y2220/71 , A23Y2220/73 , A23Y2240/75 , A23Y2300/29 , A23Y2300/49 , A23Y2300/55 , A61K8/99 , A61K35/742 , A61K35/744 , A61K35/745 , A61K2035/115 , A61K2800/10 , A61Q19/00 , Y02A50/473 , A23V2200/3204 , A23V2200/324
Abstract: Compositions include probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system.
Abstract translation: 组合物包括通过挤压使其不复制的益生菌微生物。 这样的组合物可用于治疗或预防与受损免疫系统相关的病症。
-
公开(公告)号：US20150079056A1
公开(公告)日：2015-03-19
申请号：US14550156
申请日：2014-11-21
Applicant: NESTEC S.A.
Inventor： Annick Mercenier , Sophie Nutten , Guenolee Prioult
CPC classification number: A61K35/745 , A23K10/18 , A23L33/135 , A23L33/40 , A23V2002/00 , A23Y2220/03 , A23Y2220/15 , A23Y2220/17 , A23Y2220/43 , A23Y2220/63 , A23Y2220/71 , A23Y2220/73 , A23Y2240/41 , A23Y2240/75 , A23Y2300/29 , A23Y2300/49 , A23Y2300/55 , A61K35/74 , A61K35/744 , A61K35/747 , C12N1/005 , C12N1/20 , C12N1/36 , Y02A50/473
Abstract: The present invention relates to the field of infant cereals. In particular, the present invention relates to the field of infant cereals that can be used to strengthen the immune system of the infant and/or that can be used to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to an infant cereal comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms.
Abstract translation: 本发明涉及婴儿谷物领域。 特别地，本发明涉及可用于加强婴儿免疫系统和/或可用于治疗或预防炎症性疾病的婴儿谷物领域。 例如，这些益处可以由益生菌微生物提供。 本发明的一个实施方案涉及包含非复制益生菌微生物的婴儿谷物，例如生物活性热处理的益生菌微生物。
-
Patent Agency Ranking
4.发明授权公开(公告)号：US08802077B2
公开(公告)日：2014-08-12
申请号：US13901176
申请日：2013-05-23
Applicant: Nestec S.A.
Inventor： Velerie Petit , Clara Garcia-Rodenas , Monique Julita , Guenolee Prioult , Annick Mercenier , Sophie Nutten
IPC: A01N63/00
CPC classification number: A61K35/745 , A23K10/18 , A23L33/135 , A23L33/40 , A23V2002/00 , A23Y2220/03 , A23Y2220/15 , A23Y2220/17 , A23Y2220/43 , A23Y2220/63 , A23Y2220/71 , A23Y2220/73 , A23Y2240/41 , A23Y2240/75 , A23Y2300/29 , A23Y2300/49 , A23Y2300/55 , A61K35/747 , C12N1/36 , Y02A50/473
Abstract: The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of B. longum NCC2705 (deposit number CNCM 1-2618) for use in the treatment or prevention of disorders related to the immune system including infections.
Abstract translation: 本发明一般涉及预防和/或治疗炎性和感染性疾病的领域，特别是通过增强内源性抗微生物防御。 本发明的一个实施方案是使用B. longum NCC2705（保藏号CNCM 1-2618）用于治疗或预防与包括感染在内的免疫系统相关的病症。
-
5.发明申请HEAT-TREATED FORMULATION OF BIFIDOBACTERIUM LACTIS NCC 2818 REDUCES ALLERGIC MANIFESTATIONS 审中-公开双歧杆菌NCC 2818的热处理制剂减少过敏反应公开(公告)号：US20160303226A1
公开(公告)日：2016-10-20
申请号：US15038666
申请日：2014-11-04
Applicant: NESTEC S.A.
Inventor： Annick Mercenier , Guenolee Prioult
CPC classification number: A61K39/35 , A23C9/123 , A23C9/152 , A23K10/16 , A23K50/40 , A23L33/135 , A23L33/40 , A23V2002/00 , A23V2200/00 , A23Y2300/49 , A61K9/0053 , A61K9/0095 , A61K35/745 , A61K2039/522 , A61K2039/542 , A61K2039/577 , A61K2039/58 , A23V2200/304 , A23V2200/3202 , A23V2200/3204
Abstract: Heat treated Bifidobacterium lactis NCC 2818 reduces the symptoms of allergies in different groups of patients, such as allergies originating from food allergens in young children, or infants, and food, respiratory and cutaneous allergens in children, adults and household pets. The heat treated Bifidobacterium lactis NCC 2818 may be administered alone or in a composition. A reduction of allergy symptoms has been measured, in vivo, in a mouse allergy model.
Abstract translation: 热处理的双乳双歧杆菌NCC 2818减少了不同组患者的过敏症状，例如儿童，成人和家庭宠物中幼儿或儿童食物过敏原的过敏症，食物，呼吸道和皮肤过敏原。 热处理的乳酸双歧杆菌NCC2818可以单独施用或组合施用。 在体内，在小鼠过敏模型中已经测量出过敏症状的减少。
-
6.发明授权公开(公告)号：US09320767B2
公开(公告)日：2016-04-26
申请号：US14541434
申请日：2014-11-14
Applicant: NESTEC S.A.
Inventor： Annick Mercenier , Antoine Wermeille , Audrey Demont , Guenolee Prioult
IPC: A01N63/00 , A01N63/02 , A61K35/00 , A61K35/747 , A23K1/00 , A23L1/00 , A23L1/30 , A61K35/744 , A61Q19/00 , A61K8/99 , A61K35/742 , A61K35/745
CPC classification number: A61K35/747 , A23K10/16 , A23K10/18 , A23K40/20 , A23K40/25 , A23L33/135 , A23P30/25 , A23V2002/00 , A23Y2220/03 , A23Y2220/15 , A23Y2220/17 , A23Y2220/43 , A23Y2220/49 , A23Y2220/63 , A23Y2220/71 , A23Y2220/73 , A23Y2240/75 , A23Y2300/29 , A23Y2300/49 , A23Y2300/55 , A61K8/99 , A61K35/742 , A61K35/744 , A61K35/745 , A61K2035/115 , A61K2800/10 , A61Q19/00 , Y02A50/473 , A23V2200/3204 , A23V2200/324
Abstract: The present invention generally relates to the field of pro biotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system.
Abstract translation: 本发明一般涉及生物微生物领域，特别涉及非复制益生菌微生物领域。 本发明的实施方案涉及通过挤出而不能复制的益生菌微生物的组合物。 这样的组合物可用于治疗或预防与受损免疫系统相关的病症。
-
7.发明申请公开(公告)号：US20150072033A1
公开(公告)日：2015-03-12
申请号：US14541434
申请日：2014-11-14
Applicant: NESTEC S.A.
Inventor： Annick Mercenier , Antoine Wermeille , Audrey Demont , Guenolee Prioult
CPC classification number: A61K35/747 , A23K10/16 , A23K10/18 , A23K40/20 , A23K40/25 , A23L33/135 , A23P30/25 , A23V2002/00 , A23Y2220/03 , A23Y2220/15 , A23Y2220/17 , A23Y2220/43 , A23Y2220/49 , A23Y2220/63 , A23Y2220/71 , A23Y2220/73 , A23Y2240/75 , A23Y2300/29 , A23Y2300/49 , A23Y2300/55 , A61K8/99 , A61K35/742 , A61K35/744 , A61K35/745 , A61K2035/115 , A61K2800/10 , A61Q19/00 , Y02A50/473 , A23V2200/3204 , A23V2200/324
Abstract: The present invention generally relates to the field of pro biotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic microorganisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system.
Abstract translation: 本发明一般涉及生物微生物领域，特别涉及非复制益生菌微生物领域。 本发明的实施方案涉及通过挤出而不能复制的益生菌微生物的组合物。 这样的组合物可用于治疗或预防与受损免疫系统相关的病症。
-
8.发明申请BIFIDOBACTERIUM LONGUM NCC2705 (CNCM I-2618) AND IMMUNE DISORDERS 有权双歧杆菌NCC2705（CNCM I-2618）和免疫缺陷病毒公开(公告)号：US20130260440A1
公开(公告)日：2013-10-03
申请号：US13901176
申请日：2013-05-23
Applicant: NESTEC S.A.
Inventor： Valerie Petit , Clara Garcia-Rodenas , Monique Julita , Guenolee Prioult , Annick Mercenier , Sophie Nutten
IPC: C12N1/36
CPC classification number: A61K35/745 , A23K10/18 , A23L33/135 , A23L33/40 , A23V2002/00 , A23Y2220/03 , A23Y2220/15 , A23Y2220/17 , A23Y2220/43 , A23Y2220/63 , A23Y2220/71 , A23Y2220/73 , A23Y2240/41 , A23Y2240/75 , A23Y2300/29 , A23Y2300/49 , A23Y2300/55 , A61K35/747 , C12N1/36 , Y02A50/473
Abstract: The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of B. longum NCC2705 (deposit number CNCM 1-2618) for use in the treatment or prevention of disorders related to the immune system including infections.
Abstract translation: 本发明一般涉及预防和/或治疗炎性和感染性疾病的领域，特别是通过增强内源性抗微生物防御。 本发明的一个实施方案是使用B. longum NCC2705（保藏号CNCM 1-2618）用于治疗或预防与包括感染在内的免疫系统相关的病症。
-
-
-
-
-
-
-
Search Results
8
records
(took 0.031 seconds)
